Kaleido Biosciences Inc
OTC:KLDO
Kaleido Biosciences Inc
OTC:KLDO
Price:
0.0001
USD
Market Closed
Market Cap:
$4.3k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Kaleido Biosciences Inc
OTC:KLDO
|
US |
|
A
|
Arizon RFID Technology Cayman Co Ltd
TWSE:6863
|
KY |
|
Domino's Pizza Group PLC
LSE:DOM
|
UK |
|
W
|
Wooree E&L Co Ltd
KOSDAQ:153490
|
KR |
|
K
|
Kleannara Co Ltd
KRX:004540
|
KR |
|
Cleanaway Co Ltd
TWSE:8422
|
TW |
|
G
|
Glencore PLC
JSE:GLN
|
CH |
|
Acquazzurra SpA
MIL:ACQ
|
IT |
|
Saudi Tadawul Group Holding Company SJSC
SAU:1111
|
SA |
Balance Sheet
Balance Sheet Decomposition
Kaleido Biosciences Inc
Kaleido Biosciences Inc
Balance Sheet Decomposition is not available for
Kaleido Biosciences Inc
Kaleido Biosciences Inc
Balance Sheet
Kaleido Biosciences Inc
Kaleido Biosciences Inc
Currency: USD
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
3
|
28
|
76
|
71
|
46
|
38
|
|
| Cash Equivalents |
3
|
28
|
76
|
71
|
46
|
38
|
|
| Total Receivables |
2
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
2
|
3
|
4
|
|
| Total Current Assets |
4
|
29
|
76
|
73
|
49
|
42
|
|
| PP&E Net |
1
|
2
|
5
|
7
|
8
|
6
|
|
| PP&E Gross |
1
|
2
|
5
|
7
|
8
|
6
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
3
|
3
|
5
|
|
| Other Long-Term Assets |
0
|
0
|
4
|
2
|
2
|
2
|
|
| Total Assets |
5
N/A
|
31
+516%
|
85
+177%
|
82
-4%
|
59
-28%
|
50
-16%
|
|
| Liabilities | |||||||
| Accounts Payable |
1
|
1
|
3
|
2
|
5
|
6
|
|
| Accrued Liabilities |
0
|
3
|
7
|
7
|
7
|
7
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
3
|
16
|
|
| Other Current Liabilities |
0
|
0
|
0
|
1
|
1
|
1
|
|
| Total Current Liabilities |
1
|
4
|
11
|
10
|
17
|
30
|
|
| Long-Term Debt |
5
|
15
|
15
|
20
|
18
|
6
|
|
| Other Liabilities |
0
|
3
|
2
|
3
|
4
|
4
|
|
| Total Liabilities |
6
N/A
|
22
+251%
|
28
+29%
|
33
+18%
|
39
+16%
|
40
+2%
|
|
| Equity | |||||||
| Common Stock |
16
|
53
|
153
|
0
|
0
|
0
|
|
| Retained Earnings |
17
|
44
|
106
|
193
|
274
|
364
|
|
| Additional Paid In Capital |
0
|
1
|
10
|
241
|
295
|
375
|
|
| Total Equity |
1
N/A
|
9
N/A
|
57
+546%
|
49
-14%
|
21
-58%
|
11
-48%
|
|
| Total Liabilities & Equity |
5
N/A
|
31
+516%
|
85
+177%
|
82
-4%
|
59
-28%
|
50
-16%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
29
|
29
|
29
|
30
|
36
|
43
|
|
Switch to:
Switch to:
See Also
Discover More
